-Akira Nakashima Researcher Activity Profile

Research Author Detailed Information 

Akira Nakashima Publication Rate By Year

Akira Nakashima has published 1 paper(s) in 2006, 7 paper(s) in 2007, 5 paper(s) in 2008, for a total of 13 research publications in total.

Akira A Nakashima Author Information

LAST NAME: nakashima

FIRST NAME: akira

INITIALS: A

AFFILIATION:

Papers

Akira Nakashima's Publication Record

1. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. Year Published: 2006
The Joseph Stokes Jr. Research Institute, The Children's Hospital of Philadelphia and The University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
2. RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase. Year Published: 2007
Department of Physiology, School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
3. RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase. Year Published: 2007
Department of Physiology, School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
4. [A case of advanced breast cancer leading to DIC after chemotherapy] Year Published: 2007
Dept. of Surgery, Himeji Red Cross Hospital.
5. [A case of advanced breast cancer leading to DIC after chemotherapy] Year Published: 2007
Dept. of Surgery, Himeji Red Cross Hospital.
6. [A case of advanced breast cancer leading to DIC after chemotherapy] Year Published: 2007
Dept. of Surgery, Himeji Red Cross Hospital.
7. [A case of advanced breast cancer leading to DIC after chemotherapy] Year Published: 2007
Dept. of Surgery, Himeji Red Cross Hospital.
8. Successful preoperative diagnosis of a rare bowel obstruction: cecal volvulus. Year Published: 2008
Department of Surgery, Akiota-town Togochi Hospital, 800-1 Oaza-Togochi, Akiota-cho, Yamagata-gun, Hiroshima, 731-3810, Japan.
9. RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase. Year Published: 2007
Department of Physiology, School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
10. [A Case of Dihydropyrimidine Dehydrogenase (DPD) Deficiency with Severe Side Effects from UFT/Uzel Administration.] Year Published: 2008
Dept. of Surgery, Himeji Red Cross Hospital.
11. [A Case of Dihydropyrimidine Dehydrogenase (DPD) Deficiency with Severe Side Effects from UFT/Uzel Administration.] Year Published: 2008
Dept. of Surgery, Himeji Red Cross Hospital.
12. [A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration] Year Published: 2008
Dept. of Surgery, Himeji Red Cross Hospital.
13. [A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration] Year Published: 2008
Dept. of Surgery, Himeji Red Cross Hospital.